RAC 3.62% $1.58 race oncology ltd

See you no 100$, page-8

  1. 466 Posts.
    lightbulb Created with Sketch. 76
    The buyers must already be discussing RAC IMHO and might already be doing their own due diligence on Bisantrene (off the record of course). I don't think it will last until the end of 2022, unless the current trials fall over of course.
    If you currently own Keytruda (and other drugs), you really shouldn't allow yourself to not be fully aware of what Bisantrene could offer and if you don't currently own Keytruda (and other drugs) you also shouldn't allow yourself to not be fully aware of what Bisantrene could offer. Every big pharma would know what is happening here by now and are considering their moves, because that is the business they are all in. The question is when will we know about their plans?
    Last edited by cableguy1411: 25/02/21
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.58
Change
0.055(3.62%)
Mkt cap ! $268.4M
Open High Low Value Volume
$1.56 $1.61 $1.56 $106.0K 67.13K

Buyers (Bids)

No. Vol. Price($)
2 649 $1.58
 

Sellers (Offers)

Price($) Vol. No.
$1.59 3000 1
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.